Sector: Pharmaceuticals & Biotechnology

Small Cap

Remus Pharma Share Price

REMUS

₹720

0.40(0.06%)

27th Jul 2026 | 3:18 PM

NSE : REMUS

Open Free Demat Account

Remus Pharma Performance

Price Movement

₹720.00

₹719.00

₹726.00

↘ Today's Low↗ Today's High

1 Year Performance

₹720.00

₹580.00

₹983.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹726.00

Low₹719.00

Open at₹719.00

Prev Close₹719.60

Volumes2.20 K

Avg Price₹723.11

Lower Circuit₹575.70

Upper Circuit₹863.50

Historical Performance

3M High₹937.00

3M Low₹621.30

1 Yr High₹978.65

1 Yr Low₹580.00

3 Yr High₹1,417.38

3 Yr Low₹456.25

5 Yr High₹1,417.38

5 Yr Low₹213.91

Summary

As of 28-07-2026 02:51, Remus Pharmaceuticals Ltd. share price today is ₹0, with a change of ₹-719.60 (-100.00%) from the previous close of ₹719.6. The stock opened at ₹719 and traded between ₹719 and ₹726, with a total traded volume of 2200 shares. The company has a market capitalization of ₹848 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹983 and ₹580, respectively.

Remus Pharmaceuticals Ltd. valuation metrics include a P/E ratio of 22.9, EPS of ₹39.19, and book value of ₹2.40. Profitability indicators show ROE of 10.53% along with a dividend yield of 0.1%.

Remus Pharmaceuticals Ltd. technical indicators include Day RSI at 43.53, Day MFI at 32.51, Day ADX at 14.3. Additional indicators include Commodity Channel Index (CCI) at -103.7 and Williams %R at -82.82. Momentum indicators show Day MACD at -7.72, Day MACD Signal Line at -4.25, DayATR at 25.3. Rate of Change indicators for Remus Pharmaceuticals Ltd. include ROC125 at 1.93 and ROC21 at -10.26.

Exponential moving averages include EMA5 at ₹727.1, EMA10 at ₹732.8, EMA12 at ₹734.9, EMA20 at ₹740.8, EMA26 at ₹742.6, EMA50 at ₹738.8, EMA100 at ₹728.2, EMA200 at ₹748.6. Simple moving averages include SMA5 at ₹727.5, SMA10 at ₹729.6, SMA20 at ₹745.5, SMA30 at ₹757.4, SMA50 at ₹755.2, SMA100 at ₹705.6, SMA150 at ₹703.7, SMA200 at ₹706.

Support levels for Remus Pharma are placed at First Support ₹717.43, Second Support ₹715.27, Third Support ₹712.48. Resistance levels are seen at First Resistance ₹722.38, Second Resistance ₹725.17, Third Resistance ₹727.33. Remus Pharmaceuticals Ltd. shareholding pattern shows promoter holding at 70.95%, FII holding at 5.28%, DII holding at 0%, public holding at 22.93%.

Remus Pharma Fundamentals

Market Cap

Above industry Median

848 Cr.

PE Ratio (TTM)

Below industry Median

22.90

Dividend Yield

Low in industry

0.10

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

7% decr over last year

10.53

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

Below industry Median

2.40

MFI

MFI is mid-range

32.51

RSI

RSI is mid-range

43.53

EPS (TTM)

39.19

Debt to Equity

0.07

Face Value

Operating Profit Margin Qtr.

6.59

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

2.40

Remus Pharma Financials

Data not available for chart

Indicator
No Record Found

Remus Pharma Technicals

Remus Pharmaceuticals Ltd. EMA & SMA

₹720.00

-3.20 (-0.44%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹727.1

Day EMA10 ₹732.8

Day EMA12 ₹734.9

Day EMA20 ₹740.8

Day EMA26 ₹742.6

Day EMA50 ₹738.8

Day EMA100 ₹728.2

Day EMA200 ₹748.6

Remus Pharma Support and Resistance

Resistance

First Resistance₹722.38

Second Resistance₹725.17

Third Resistance₹727.33

Support

First Support₹717.43

Second Support₹715.27

Third Support₹712.48

Technical Indicators

Day RSI43.53

Day MFI32.51

Day ADX14.30

Day Commodity Channel Index-103.70

William-82.82

Day MACD-7.72

Day MACD Signal Line-4.25

Day ATR25.30

Day ROC1251.93

Day ROC21-10.26

Remus Pharma Shareholding Pattern

Held By	Mar 2025	Sep 2025	Mar 2026
Promoter	70.8	70.9	71
FII	4.8	5	5.3
DII	0.7	0.8	0.8
Public	23.6	23.3	22.9

Remus Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1.6 K	1.9 K	84.21%
Week	1.14 K	1.42 K	80.28%
1 Month	3.81 K	4.62 K	82.56%
6 Month	4.49 K	6.09 K	73.74%

Remus Pharma SWOT Analysis

Strengths7

Weakness10

Opportunity0

Threats0

Benjamin Graham Value Screen

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Companies with Zero Promoter Pledge

Remus Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
14 Nov, 2025	0.5	INTERIM	14 Nov, 2025	Equity Share
18 Sep, 2025	0.5	FINAL	18 Sep, 2025	Equity Share
19 Nov, 2024	1	INTERIM	20 Nov, 2024	Equity Share
02 May, 2024	4	INTERIM	02 May, 2024	Equity Share
27 Oct, 2023	2	INTERIM	28 Oct, 2023	Equity Share

Remus Pharma Stock Comparison

Financials	Bio Medica Laboratories Ltd.	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.
Price (₹)	₹141.55	₹558	₹5.22	₹111.80	₹160	₹15.84
% Change	2.05%	4.18%	0.77%	-0.18%	-1.84%	5.53%
Revenue TTM (₹ Cr)	-	-	₹69.99	-	₹287.68	₹176.50
Net Profit TTM (₹ Cr)	-	-	₹-176.47	-	₹14.88	₹27.81
PE TTM	66.30	-	-0.20	13.10	42.50	28.70
1 Year Return	-0.22	36.63	418	-12.5	29.37	64.95
ROCE	-	3.56	-56.37	-	-	17.36

Similar Stocks

MEDISTEP

Medistep Healthcare Ltd.

₹ 18.50

-6.33%

INFLUX

Influx Healthtech Ltd.

₹ 285.00

-1.77%

MEDIORG

Medicamen Organics Ltd.

₹ 25.50

+3.24%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 513.10

+0.81%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 62.00

+0.81%

SIGACHI

Sigachi Industries Ltd.

₹ 25.94

+1.73%

WINDLAS

Windlas Biotech Ltd.

₹ 861.95

+0.47%

VINEETLAB

Vineet Laboratories Ltd.

₹ 38.88

+0.93%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 502.10

+2.06%

ZIMLAB

Zim Laboratories Ltd.

₹ 118.00

-1.99%

MEDICO

Medico Remedies Ltd.

₹ 41.65

+9.63%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 187.00

+1.86%

LASA

Lasa Supergenerics Ltd.

₹ 6.86

-1.15%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 316.60

-0.24%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 319.90

-1.07%

ORTINGLOBE

Ortin Global Ltd.

₹ 14.50

-2.09%

BROOKS

Brooks Laboratories Ltd.

₹ 63.70

-0.56%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2925.00

-0.41%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 242.91

+2.00%

ALPA

Alpa Laboratories Ltd.

₹ 66.90

-0.40%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 392.00

+2.86%

NECLIFE

Nectar Lifesciences Ltd.

₹ 10.40

+0.97%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 27.43

+0.77%

INDOCO

Indoco Remedies Ltd.

₹ 248.00

+1.88%

FAQ's on REMUS

What is the Market Capitalization of Remus Pharmaceuticals Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Remus Pharmaceuticals Ltd. is approximately ₹ 848 Cr.

What are the PE and PB ratios for Remus Pharmaceuticals Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Remus Pharmaceuticals Ltd. is 22.9, and the Price-to-Book (PB) ratio is 2.4.

What is the 52-Week High and Low for Remus Pharmaceuticals Ltd.?

Over the past 52 weeks, the highest price reached by Remus Pharmaceuticals Ltd. shares was ₹ 978.65, and the lowest price was ₹ 580.

What is the current dividend yield for Remus Pharmaceuticals Ltd.?

As of 6 June 2025, the dividend yield for Remus Pharmaceuticals Ltd. is 0.1%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Remus Pharmaceuticals Ltd.?

Significant shareholdings in Remus Pharmaceuticals Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Remus Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Remus Pharmaceuticals Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Remus Pharmaceuticals Ltd.?

Remus Pharmaceuticals Ltd. last declared a INTERIM dividend of ₹ 0.5 per share for the financial period ending 2025. The record date was set as 2025-11-14, and the payment was/is scheduled around 2025-11-14. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy